- Raised 6.2Mil$ in capital (from Accel Partners, Siana Capital, Barath Innovation Fund)
- Successfully Completed GLP Tox studies
- Completed DS manufacturing at 250L Scale
- Completed PIND(Pre IND submission) for ZM008
- Ex-Vivo studies ongoing : Promising date in Monotherapy and combination
